Symposium “A new era in the lives of patients with obstructive hypertrophic cardiomyopathy”

Objectives

• Review efficacy and safety data of CAMZYOS^® (mavacamenten) from pivotal clinical trials in obstructive HCM
• Discuss patient journey and identify ideal patient types for CAMZYOS
• Listen to a patient’s experience on using CAMZYOS and highlight impact/changes on his/her condition

Program

15.30 – 15.35   Introduction – Iacopo Olivotto

15.35 – 15.50   Clinical Overview of CAMZYOS in Obstructive
                              Hypertrophic Cardiomyopathy - Michelle Michels
                            - Clinical Trial Data (EXPLORER - HCM and VALOR - HCM)
                            - Dosage and Administration
                            - Hypothetical Patient Cases

15.50 – 16.10   Fireside Chat With a CAMZYOS Patient
                            - Iacopo Olivotto & Michelle Michels

16.10 – 16.15   Q&A and closing  – Iacopo Olivotto